ATRX/DAXX loss/mutations and ALT positivity are associated with a more aggressive phenotype, such as a larger tumor size, high grade, advanced stage, chromosomal instability, metastatic disease, and poor survival [16,96,98,101,117]. This evidence concerns the gene DAXX and neoplasm.